[go: up one dir, main page]

WO2008011168A3 - Glycosylated peptide antagonists of the bradykinin b1 receptor - Google Patents

Glycosylated peptide antagonists of the bradykinin b1 receptor Download PDF

Info

Publication number
WO2008011168A3
WO2008011168A3 PCT/US2007/016489 US2007016489W WO2008011168A3 WO 2008011168 A3 WO2008011168 A3 WO 2008011168A3 US 2007016489 W US2007016489 W US 2007016489W WO 2008011168 A3 WO2008011168 A3 WO 2008011168A3
Authority
WO
WIPO (PCT)
Prior art keywords
bradykinin
receptor
peptide antagonists
glycosylated peptide
disclosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2007/016489
Other languages
French (fr)
Other versions
WO2008011168A2 (en
Inventor
Amico Derin C D
Benny C Askew
Yoshitaka Ichikawa
Jonathan Duffield
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of WO2008011168A2 publication Critical patent/WO2008011168A2/en
Publication of WO2008011168A3 publication Critical patent/WO2008011168A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/18—Kallidins; Bradykinins; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/003—Peptides being substituted by heterocyclic radicals, e.g. bleomycin, phleomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

A compositions of matter and pharmaceutical compositions are disclosed, which in various embodiments, comprise biologically active glycosylated peptides that can be used therapeutically or prophylactically against diseases or conditions linked to bradykinin B1 receptor as the causative agent. A method of treating, preventing, or ameliorating a disease or condition associated with B1 activity is also disclosed.
PCT/US2007/016489 2006-07-21 2007-07-20 Glycosylated peptide antagonists of the bradykinin b1 receptor Ceased WO2008011168A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83246406P 2006-07-21 2006-07-21
US60/832,464 2006-07-21

Publications (2)

Publication Number Publication Date
WO2008011168A2 WO2008011168A2 (en) 2008-01-24
WO2008011168A3 true WO2008011168A3 (en) 2008-06-05

Family

ID=38957413

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/016489 Ceased WO2008011168A2 (en) 2006-07-21 2007-07-20 Glycosylated peptide antagonists of the bradykinin b1 receptor

Country Status (1)

Country Link
WO (1) WO2008011168A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113848686B (en) * 2021-09-26 2023-10-27 江西达诚新材料有限公司 Negative photoresist developer and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988002756A2 (en) * 1986-10-13 1988-04-21 Sandoz Ag Peptide derivatives
EP0472220A1 (en) * 1990-08-24 1992-02-26 Syntex (U.S.A.) Inc. Bradykinin antagonists

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988002756A2 (en) * 1986-10-13 1988-04-21 Sandoz Ag Peptide derivatives
EP0472220A1 (en) * 1990-08-24 1992-02-26 Syntex (U.S.A.) Inc. Bradykinin antagonists

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
C HO ET AL: "Comparison of the immunogenicity of wasp venom peptides with ot without carbohydrate moieties", TOXICON, vol. 36, no. 1, 1998, US ELMSFORD, NY, pages 217 - 221, XP005310749 *
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY, PART C: PHARMACOLOGY, TOXICOLOGY & ENDOCRINOLOGY, 105C(2), 189-96 CODEN: CBPCEE; ISSN: 0742-8413, 1993 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 1993, PIEK, T. ET AL: "Presynaptic block of transmission in the insect CNS by mono- and digalactosyl analogs of Vespulakinin 1, a wasp (Paravespula maculifrons) venom neurotoxin", XP002471227, retrieved from STN Database accession no. 119:197529 *

Also Published As

Publication number Publication date
WO2008011168A2 (en) 2008-01-24

Similar Documents

Publication Publication Date Title
WO2007002597A3 (en) Modified-release formulations of a bupropion salt
EP2455462A3 (en) Lipase variants for pharmaceutical use
WO2006119958A3 (en) Use of flibanserin in the treatment of chronic pain
WO2009009562A3 (en) Glp-1-fc fusion protein formulation
WO2006034373A8 (en) Variants and chemically-modified variants of phenylalanine ammonia-lyase
WO2007087068A3 (en) Inhibitors of tyrosine kinases and uses thereof
WO2009011544A3 (en) Insulinotropic peptide derivative wherein its n-terminal amino acid is modified
IL222879A (en) Peptides and uses thereof in the treatment and diagnosis of diseases and pharmaceutical compositions comprising the same
EP1626055A3 (en) Non-mammalian GnRH analogs and uses thereof in the regulation of the immune system
NZ623123A (en) A process for concentration of a polypeptide
WO2011156453A3 (en) Therapeutic peptides
SG149872A1 (en) Antagonists of the bradykinin b1 receptor
WO2007138466A3 (en) Pharmaceutical compositions comprising meloxicam and tramadol combination
NZ601592A (en) Recombinant elastase proteins and methods of manufacturing and use thereof
WO2008051496A3 (en) Use of il-1 antagonists to treat gout and pseudogout
EP2510941A3 (en) Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist
WO2008012796A3 (en) Pharmaceutical compositions comprising ccl2 and use of same for the treatment of inflammation
AU2003229284A1 (en) Active substances for the treatment, diagnosis and prophylaxis of diseases in which abnormal protein structures occur
WO2007007095A3 (en) Pharmaceutical compositions comprising a tgf-beta superfamily member
WO2008062475A3 (en) Pharmaceutical compositions of ursodiol
WO2007133796A3 (en) Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist
WO2006100679A3 (en) Recombinant antibodies against human type ii transglutaminase and uses thereof
EP1969003B8 (en) Uses of a NEUROTROPHIC FACTOR PROTEIN
WO2006049681A3 (en) Selective neuropeptide y2 receptor agonists
UA94213C2 (en) Use of monovalent antibody polypeptide that inhibits cd40 or cd40l activity in the manufacture of a medicament for treating or preventing autoimmune disease

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07810665

Country of ref document: EP

Kind code of ref document: A2